Exposure to anesthesia causes lipid clusters to move from an ordered state to a disordered one, then back again. These changes lead to subsequent effects that cause changes in consciousness.
Researchers report neurons in areas of the brain associated with memory formation can form networks in the absence of synaptic activity.
Those with PTSD are almost twice as likely to develop alcohol use disorder than their peers who have not experienced trauma. Researchers report drugs that block FKBP5, such as benztropine, a drug used to control symptoms of Parkinson's disease, and the experimental compound SAFit2 reduce alcohol preference and drinking in models of PTSD.
Researchers have identified a hormone that appears to trigger fat burning in the gut.
A new study reveals some experimental antibody treatments for neurodegenerative disorders increase neuroinflammation. The effect was seen in human microglia, not mouse microglia. This may explain why mouse studies have shown these treatments to be effective, but the effect has not been replicated in human studies.
Researchers have identified a biochemical cascade that leads to the destruction of synapses in the brain. The findings open new avenues of research into the treatment of Alzheimer's disease.
Study reveals up to 45% of people infected with COVID-19 were asymptomatic. The findings suggest asymptomatic infections likely played a significant role in the early and ongoing spread of coronavirus.
Study reveals how the mechanism for storing olfactory memories differs slightly from erasing unnecessary memories. Understanding how the brain gets rid of unimportant memories could help unlock new avenues of research to better understand memory loss in aging, researchers say.
Researchers shed new light on neuroplasticity by sparking learning in tadpole brains. They discovered the key to neuroplasticity is how the brain generates new proteins. Findings could help deepen understanding of sensory processing in ASD.
Researchers have determined the near-atomic scale structure of the anxiety-associated GPR158 receptor. The findings enable an avenue to create potential therapeutics to block the receptor in order to treat depression, stress, and other mental health disorders.